Effects of zonisamide on dopaminergic system

Area of Science:

• Neuropharmacology
• Dopaminergic System Research
• Drug Metabolism Studies

Background:

• Zonisamide (ZNS) is an anticonvulsant drug with a known mechanism of action that is not fully understood.
• Dopamine (DA) and its metabolites play crucial roles in various brain functions, and their dysregulation is implicated in neurological disorders.
• Understanding how ZNS affects the dopaminergic system is essential for elucidating its therapeutic mechanisms.

Purpose of the Study:

• To investigate the effects of zonisamide (ZNS) on dopamine (DA), 3,4-dihydroxyphenylalanine (DOPA), 3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA) levels in rat striatum and hippocampus.
• To determine the impact of ZNS on DOPA accumulation, DA re-uptake, and monoamine oxidase (MAO) activities in vivo.
• To explore the dose-dependent and duration-dependent effects of ZNS on dopaminergic neurotransmission.

Main Methods:

• Acute and chronic administration of therapeutic (20, 50 mg/kg) and supratherapeutic (100 mg/kg) doses of ZNS to freely moving rats.
• Measurement of extracellular and intracellular levels of DA, DOPA, DOPAC, and HVA in striatum and hippocampus using microdialysis and biochemical assays.
• Assessment of DOPA accumulation (tyrosine hydroxylase activity index), DA re-uptake, and MAO-A and MAO-B activities.

Main Results:

• Therapeutic ZNS doses increased extracellular DOPA and intracellular DOPA, DA, and HVA levels in both striatum and hippocampus, while decreasing DOPAC levels.
• ZNS stimulated DOPA accumulation, indicating enhanced tyrosine hydroxylase activity, and weakly inhibited both MAO-A and MAO-B activities.
• Supratherapeutic ZNS doses decreased intracellular levels of all measured substances and inhibited DOPA accumulation, suggesting reduced DA turnover.

Conclusions:

• Therapeutic doses of ZNS enhance dopamine synthesis and increase both intracellular and extracellular levels of DA, DOPA, and HVA, potentially by inhibiting MAO-B.
• ZNS exhibits dose-dependent effects on dopaminergic metabolism, with higher doses leading to inhibition of DA turnover.
• These modulations of dopamine metabolism by ZNS are likely integral to its overall mechanism of action.